 |
|
|
| |
ARC-520 produces deep and durable knockdown of viral
antigens and DNA in a phase II study in patients with chronic hepatitis B
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco, CA
Man---Fung Yuen1, Henry Lik Yuen Chan2, Kevin Liu1, Bruce D. Given3, Thomas Schluep3, James Hamilton3, Ching-Lung Lai1, Stephen A. Locarnini4, Johnson YN Lau5, Carlo Ferrari6, Robert G. Gish7,8
1The University of Hong Kong, Hong Kong, China;
2 The Chinese University of Hong Kong, Hong Kong, China;
3 Arrowhead Research Corporation, Pasadena, CA;
4 Victorian Infectious Diseases Reference Laboratory, Victoria, Australia;
5Hong Kong Polytechnic University, Hong Kong, China;
6 University of Parma, Parma, Italy
7 Stanford University, Palo Alto, CA;
8 Hepatitis B Foundation, Doylestown, PA
|
| |
|
|
|
|
|
